|
Acoramidis (AG10) oral tablet Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 4: 1
Top Sponsors
- Eidos Therapeutics, a BridgeBio company1
Indications
- Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)1
- Transthyretin Amyloidosis1
- Amyloid Cardiomyopathy1
- Alzheimer's Disease1
- Heart Disease1
St Louis, Missouri1 trial
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Washington University in St. Louis
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.